HEMATOLOGIC CHANGES IN RAT FOLLOWING ADMINISTRATION OF DESOXYPYRIDOXINE, AMINOPTERIN, OXYTHIAMINE AND 6,7-DIMETHYL-9-(2'-ACETOXYETHYL)ISOALLOXAZINE

被引：2

|

作者：

DOCTOR, VM

机构：

来源：

BLOOD | 1959年 / 14卷 / 11期

关键词：

D O I：

10.1182/blood.V14.11.1244.1244

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1244 / 1249

页数：6

相关论文

共 8 条

[1] THE COMPARATIVE PHARMACOLOGY IN MAN AND THE RAT OF THE RIBOFLAVIN ANALOGUE, 6,7-DIMETHYL-9-(2'-ACETOXYETHYL)-ISOALLOXAZINE, U-2112
LANE, M
FAHEY, JL
SULLIVAN, RD
ZUBROD, CG
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1958, 122 (03): : 315 - 326
[2] METABOLITE INHIBITORS .1. 6,7-DIMETHYL-9-FORMYLMETHYLISOALLOXAZINE, 6,7-DIMETHYL-9-(2'-HYDROXYETHYL)-ISOALLOXAZINE AND DERIVATIVES
FALL, HH
PETERING, HG
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1956, 78 (02) : 377 - 380
[3] ISOLATION AND CHARACTERIZATION OF 6,7-DIMETHYL-9-(2'-HYDROXYETHYL)-ISOALLOXAZINE AS A BACTERIAL FERMENTATION PRODUCT OF RIBOFLAVIN
MILES, HT
STADTMAN, ER
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1955, 77 (21) : 5746 - 5747
[4] POLAROGRAPHIC STUDY OF PHOTOLYSIS AND PHTOREDUCTION OF RIBOFLAVIN AND 6,7-DIMETHYL-9-(FORMYLMETHYL-)ISOALLOXAZINE
KNOBLOCH, E
BIOCHIMICA ET BIOPHYSICA ACTA, 1967, 141 (01) : 19 - &
[5] STUDIES ON CARCINOLYTIC COMPOUNDS .5. 6,7-DIMETHYL-9-[1'-(5-DESOXY-D-RIBITYL)]-ISOALLOXAZINE
SHUNK, CH
LAVIGNE, JB
FOLKERS, K
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1955, 77 (08) : 2210 - 2212
[6] SYNTHESIS, PHARMACOLOGY, AND CLINICAL TRIAL OF THE RIBOFLAVINE ANALOGUE, SODIUM-6,7-DIMETHYL-9-(2'-HEMISUCCINOXYETHYL)-ISOALLOXAZINE, U-6538
LANE, M
PETERING, HG
BRINDLEY, CO
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1959, 22 (02) : 349 - 361
[7] HISTOPATHOLOGICAL AND ULTRASTRUCTURAL-CHANGES IN THE JUXTAGLOMERULAR APPARATUS OF THE RAT FOLLOWING ADMINISTRATION OF ZENECA ZD6888 (2-ETHYL-5,6,7,8-TETRAHYDRO-4-[(2'-( 1H-TETRAZOL-5-YL)BIPHENYL-4-YL)-METHOXY]QUINOLINE), AN ANGIOTENSIN-II ANTAGONIST
JACKSON, DG
JONES, HB
TOXICOLOGIC PATHOLOGY, 1995, 23 (01) : 7 - 15
[8] Quantitative measurement of changes in amyloid-β(40) in the rat brain and cerebrospinal fluid following treatment with the γ-secretase inhibitor LY-411575 [N2-[(2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-L-alaninamide]
Best, JD
Jay, MT
Otu, F
Ma, J
Nadin, A
Ellis, S
Lewis, HD
Pattison, C
Reilly, M
Harrison, T
Shearman, MS
Williamson, TL
Atack, JR
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 313 (02): : 902 - 908